PII-LBA9 EFFICACY AND SAFETY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OAB SUBJECTS WITH AN INADEQUATE RESPONSE TO INITIAL 4-WEEK SOLIFENACIN MONOTHERAPY